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Abstract
Nonenzymatic post-translational modification (PTM) of proteins is a fundamental molecular process of
aging. The combination of various modifications and their accumulation with age not only affects
function, but leads to crosslinking and protein aggregation. In this study, aged human lens proteins were
examined using HPLC–tandem mass spectrometry and a blind PTM search strategy. Multiple thioether
modifications of Ser and Thr residues by glutathione (GSH) and its metabolites were unambiguously
identified. Thirty-four of 36 sites identified on 15 proteins were found on known phosphorylation sites,
supporting a mechanism involving dehydroalanine (DHA) and dehydrobutyrine (DHB) formation through
β-elimination of phosphoric acid from phosphoserine and phosphothreonine with subsequent
nucleophilic attack by GSH. In vitro incubations of phosphopeptides demonstrated that this process can
occur spontaneously under physiological conditions. Evidence that this mechanism can also lead to
protein–protein crosslinks within cells is provided where five crosslinked peptides were detected in a
human cataractous lens. Nondisulfide crosslinks were identified for the first time in lens tissue between
βB2- & βB2-, βA4- & βA3-, γS- & βB1-, and βA4- & βA4-crystallins and provide detailed structural
information on in vivo crystallin complexes. These data suggest that phosphoserine and
phosphothreonine residues represent susceptible sites for spontaneous breakdown in long-lived proteins
and that DHA- and DHB-mediated protein crosslinking may be the source of the long-sought after
nondisulfide protein aggregates believed to scatter light in cataractous lenses. Furthermore, this
mechanism may be a common aging process that occurs in long-lived proteins of other tissues leading to
protein aggregation diseases.
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Summary
Nonenzymatic post-translational modification (PTM) of proteins
is a fundamental molecular process of aging. The combination of
various modifications and their accumulation with age not only
affects function, but leads to crosslinking and protein aggregation. In this study, aged human lens proteins were examined
using HPLC–tandem mass spectrometry and a blind PTM search
strategy. Multiple thioether modifications of Ser and Thr residues
by glutathione (GSH) and its metabolites were unambiguously
identified. Thirty-four of 36 sites identified on 15 proteins were
found on known phosphorylation sites, supporting a mechanism
involving dehydroalanine (DHA) and dehydrobutyrine (DHB)
formation through b-elimination of phosphoric acid from phosphoserine and phosphothreonine with subsequent nucleophilic
attack by GSH. In vitro incubations of phosphopeptides demonstrated that this process can occur spontaneously under physiological conditions. Evidence that this mechanism can also lead to
protein–protein crosslinks within cells is provided where five
crosslinked peptides were detected in a human cataractous lens.
Nondisulfide crosslinks were identified for the first time in lens
tissue between bB2- & bB2-, bA4- & bA3-, cS- & bB1-, and bA4- &
bA4-crystallins and provide detailed structural information on in
vivo crystallin complexes. These data suggest that phosphoserine
and phosphothreonine residues represent susceptible sites for
spontaneous breakdown in long-lived proteins and that DHAand DHB-mediated protein crosslinking may be the source of the
long-sought after nondisulfide protein aggregates believed to
scatter light in cataractous lenses. Furthermore, this mechanism
may be a common aging process that occurs in long-lived
proteins of other tissues leading to protein aggregation diseases.
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Introduction
Long-lived proteins are subject to numerous post-translational modifications including racemization, oxidation, glycation, truncation, and
deamination. (Robinson & Robinson, 2001; Stadtman, 2001; Soskic
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et al., 2008; Jaisson & Gillery, 2010; Truscott, 2011). These modifications often result in functional deficits and have been causally implicated
in diseases such as diabetes mellitus, Alzheimer’s disease, atherosclerosis
(Jaisson & Gillery, 2010) and may ultimately lead to reduced lifespan
(Truscott, 2011). Among the longest-lived proteins in the body are
proteins of the ocular lens. Remarkably, there is no significant protein
turnover in differentiated lens fiber cells; therefore, the center of the lens
contains proteins as old as the organism (Lynnerup et al., 2008), and this
fact makes it a convenient tissue to study age-related post-translational
modifications.
With age, a number of biochemical and biophysical changes occur in
the lens and extensive studies have been conducted to elucidate agerelated changes in human lens proteins. Besides lens protein truncation
(Lampi et al., 1998; Grey & Schey, 2009), significant changes to lens
proteins include protein aggregation leading to an increase in high
molecular weight complexes and a reduction in protein solubility
(Harrington et al., 2004). In age-related nuclear cataract lenses, a
significant amount of high molecular weight complex remains even after
the tissue has been treated with denaturing and reducing agents,
suggesting the formation of nondisulfide covalent protein–protein
crosslinks (Dilley & Pirie, 1974; Srivastava et al., 2004). It is thought
that protein aggregation, crosslinking, and insolubilization processes
contribute to the development of age-related lens opacity (Dilley & Pirie,
1974). Similar protein aggregation processes are also common features
of aging of other long-lived postmitotic cells such as neurons, retinal
pigment epithelium, cardiac myocytes, and skeletal muscle fibers (Grune
et al., 2004; Goebel & Blaschek, 2011; Polymenidou & Cleveland, 2011).
Understanding the factors that lead to protein–protein crosslinking is
critically important in elucidating the aging process and in identifying
disease-specific crosslinks. Evidence suggests that a variety of posttranslational modifications and oxidative stress could contribute to
protein–protein aggregation and crosslinking. Several crosslinking mechanisms have been proposed based on the identification of crosslinked
compounds such as advanced glycation end products (Nagaraj et al.,
1991), c-glutamyl-e-lysine (Lorand et al., 1981), lanthionine (LAN),
histidinoalanine (HAL), and lysinoalanine (LAL) (Kanayama et al., 1987;
Linetsky et al., 2004; Linetsky & LeGrand, 2005); however, the exact
proteins and sites of crosslinking remain unknown.
Lanthionine, HAL, and LAL are crosslinks formed through a dehydroalanine (DHA) intermediate. DHA is detected in food proteins that have
been treated with heat or alkali (Sen et al., 1977). The formation of DHA
results from a hydroxide ion-induced b-elimination reaction, a process
that can also occur in long-lived proteins under physiological conditions
as evidenced by the detection of DHA in tissues such as human lens
(Srivastava et al., 2004) and dentin (Masters, 1985; Cloos & Jensen,
2000). The amino acid residues that can undergo decomposition to DHA
include cysteine (Bar-Or et al., 2008), serine, and phosphoserine (Sen
et al., 1977; Cloos & Jensen, 2000). DHA is reactive and is subject to
nucleophilic attack by cysteine, histidine, and lysine to form LAN, HAL,
and LAL, respectively. Although free amino acids in tissues can add to
DHA, if lysine, histidine, or cysteine residues react with DHA, this
reaction can lead to intramolecular and intermolecular protein–protein
crosslinks (Bessems et al., 1987; Cloos & Jensen, 2000; Linetsky et al.,
2004). LAN, HAL, and LAL have been detected in dentin (Cloos & Jensen,
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2000) as well as in normal and cataractous lenses, with the level of these
potential crosslinks being significantly higher in cataractous lenses
(Bessems et al., 1987; Linetsky et al., 2004). Previous identification of
LAN, HAL, and LAL in aged tissues was based on the analysis of acidhydrolyzed samples; however, heat increases the formation of DHA
(Samuel & Silver, 1963) and the subsequent nucleophilic addition can
also be catalyzed by acid (Singh & Goswami, 2008), which raises a
concern of artifactual crosslink formation induced by acid hydrolysis. In
addition, acid hydrolysis removes any information of which proteins, if
any, are involved in the crosslinking process. Detailed information of
which proteins are crosslinked and how they are crosslinked is essential
to distinguish normal aging and disease processes. In addition to being a
key participant in protein–protein crosslinking, DHA is expected to react
with free thiols and amines to produce covalently modified proteins.
Linetsky et al. reported glutathionylation of lens proteins via a DHA
intermediate using ELISA (Linetsky & LeGrand, 2005); however, this
method could not identify the proteins or amino acids involved.
In the present study, we identified polypeptides that are modified by
glutathione, cysteine, and glycine–cysteine dipeptide as well as homocysteine through thioether linkages. Our findings support a mechanism
involving glutathione addition to a DHA residue. If DHA were indeed
being formed, it could also act to crosslink proteins and additional results
unambiguously confirmed DHA-mediated protein–protein crosslinks in
aged lens proteins. Our results, for the first time, identify the sites in
human proteins that are modified by free thiol compounds through
thioether bonds and also elucidate the sites of novel covalent crosslinking of proteins in a cataractous lens. Our results provide direct evidence
for a mechanism involving spontaneous formation of DHA and DHB
intermediates from phosphoserine, phosphothreonine as well as cysteine, leading to protein modification and protein–protein crosslinking.
The methods used in this study can be used as a guide to identify similar
modifications and protein–protein crosslinks in long-lived proteins from
other tissues.

Results
Figure 1 indicates the predicted reactions leading to observed products
characterized below.

Identification of modifications on Ser and Thr in the normal
human lens
Multidimensional LC-MS/MS analyses of trypsin-digested lens membrane
fractions analyzed by TagRecon using a blind modification search
revealed a 160 amu addition to Ser residues on lens proteins such as
AQP0, MP20, and several crystallins. A representative tandem mass
spectrum is shown in Fig. 2 for modified AQP0 229-238. The tandem

mass spectrum clearly indicates that the modification is on a single Ser
residue (Fig. 2), ruling out the possibility of phosphorylation at two
distinct sites. Moreover, the accurate mass of the modified peptide
obtained from the Orbitrap mass spectrometer does not match the
predicted peptide masses for diphosphorylation or pyrophosphorylation
within the instrument mass accuracy of < 5 ppm. The mass addition of
160.0288 amu suggests modification by a Cys-Gly dipeptide through a
thioether bond (peptide mass error = 1.04 ppm). The most likely origin
of Cys-Gly is from the breakdown of GSH based on in vitro results shown
in Fig. 3 (discussed below). Based on the identification of a thioether
modification, all tandem mass spectra were re-searched for differential
modifications on Ser and Thr residues by thiol-containing molecules such
as GSH, Cys, Cys-Gly, and homocysteine. Modification on Ser and Thr
residues through a thioether bond was further confirmed by the
identification of modification by GSH as well as Cys and homocysteine.
Based on both accurate mass (within 5 ppm) and manual interpretation
of tandem mass spectra, 36 different sites on 15 human lens proteins
were identified as sites modified by thiol compounds (Table 1; (iii) in
Fig. 1). Among them, 26 sites were modified by GSH, 17 sites were
modified by Cys-Gly, and 13 sites were modified by cysteine. Only one
site modified by homocysteine was identified perhaps reflecting the
native concentrations of free homocysteine. In addition to thiol groups,
lysine was also found to modify four proteins at four of the same sites as
thiol modification, suggesting that a DHA intermediate is formed.
Histidine modification of Ser or Thr residues was not observed. All of the
modification sites reported in this paper except T170 in aB-crystallin and
S34 in MP20 have been confirmed as phosphorylation sites in previous
publications of the lens phosphoproteome (Huang et al., 2011; Wang
et al., 2013). These results confirm a previous report that DHA can be
formed from Ser or pSer residues under physiological conditions and can
react with free thiol or amine groups (Masters, 1985). Importantly, the
exact sites of modification have not been identified previously. In
addition to Ser and pSer, DHA can also be formed from cysteine residues
through the loss of H2S (Bar-Or et al., 2008). Endogenous DHA
formation and GSH modification of a Cys residue were observed on
Cys 5 in bA4-crystallin (Fig. S1). Similar modifications to those shown in
Table 1 were observed in the water-soluble fraction (WSF) and ureasoluble fraction (USF).

In Vitro formation of DHA and glutathionylated peptides
To study whether the postulated two-step reaction, DHA formation
followed by thiol addition, can occur spontaneously in vitro, and to
unambiguously confirm the structures of the products, a modified
aB-crystallin peptide containing phosphorylated Ser59 [(Ac-YAP(pSer)
W); (i) in Fig. 1] was synthesized with the N-terminus of the peptide
acetylated to prevent reaction with the alpha amino group. The peptide

Fig. 1 Diagram of reactions and products
formed in human lens tissue with age.
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that GSH modification (iii) is present in the young fiber cells of the outer
cortex and the ratio of modified to unmodified peptide increases in the
inner cortex in both lens samples. In the younger lens, the level of
glutathionylation continues to increase in the nucleus, indicating the
accumulation of more modified protein with protein age. In the older
lens, the level of glutathionylation decreased in the nucleus compared to
the inner cortex. The decreasing signal of GSH-modified peptide relative
to unmodified peptide implies that further modification of the GSHmodified peptide occurs with age. In an aged (94-year-old) lens nucleus,
the ratio of GSH-modified peptide to unmodified peptide is very low (Fig. S4),
supporting the hypothesis that further degradation/modification of the
GSH-modified peptide occurs with age. The effects of GSH concentration, protein age, and protein degradation in each lens region combine
to produce the observed GSH-modified peptide abundance.

Identification of crosslinked peptides from a cataractous lens
Fig. 2 Tandem mass spectrum of AQP0 peptide 229-238 (SISERLSVLK) with
S235 modified by Cys-Gly dipeptide. [MH]2+mono = 646.3549. b- and y-ions are
labeled, and asterisks indicate fragment ions with modification.

was incubated in 100 mM phosphate buffer (pH 7.4) to study the
formation of DHA from phosphoserine. After 3 weeks at 60 °C, an
Ac-YAP(DHA)W peak could be clearly detected by HPLC as shown in
Fig. 3A. The Ac-YAP(DHA)W peptide was purified by HPLC (Fig. 3B), and
its structure was confirmed by NMR (Fig. S2). This peptide represents a
product of type (ii) in Fig. 1. Purified Ac-YAP(DHA)W was then mixed
with either GSH or phenylethylamine in 100 mM phosphate buffer (pH
7.4) and incubated at 37 °C. Both phenylethylamine and GSH reacted
readily with the DHA residue at 37 °C (Fig. 3C,D, respectively).
Diastereoisomers were detected, as expected, for both the GSH and
phenylethylamine products. The structures of both the GSH- and
phenylethylamine-modified peptides were confirmed by MS/MS analysis,
and the GSH-modified peptide is a type (iii) product in Fig. 1.
Importantly, a significant HPLC peak due to the formation of Cys-Gly
adducts was observed in the glutathione incubation (Fig. 3D). This result
suggests that loss of glutamate from the GSH peptide adducts can occur
spontaneously at neutral pH and is a natural degradation product of the
GSH-modified peptide. The time course of formation of the GSHmodified peptide from purified Ac-YAP(DHA)W is shown in Fig. 3E. The
level of the modified peptide increased over a period of hours at 37 °C
reaching a plateau after 20 h. Correspondingly, the concentration of the
DHA peptide diminished over the 24-h period and then remained steady
(data not shown). The formation of a plateau is most likely due to the
loss of GSH from the reaction mixture by conversion to its oxidized GSSG
form. A second model phosphopeptide, aquaporin-0 (AQP0) 224-241
containing pSer 235, was incubated at 37 °C with 3 mM GSH, the
concentration of GSH in cortical lens tissue. After incubation for 3 days,
a GSH-modified AQP0 peptide at S235 was detected after Lys C
digestion that was indistinguishable from the modified peptide detected
in lens samples (Fig. S3).

The level of glutathionylation of aB S59 in the different
regions of the human lenses
The relative level of glutathionylation on aB S59 in the combined watersoluble and urea-soluble fractions in two human lenses of different ages
was monitored, and the results are shown in Fig. 4. The results indicate

Based on the identification of the thiol modifications described above,
and reports of LAN, HAL, and LAL in lenses, we hypothesized that DHA
and DHB intermediates could also lead to nondisulfide protein–protein
crosslinks in aged lenses [products (iv) in Fig. 1], a phenomenon
associated with human nuclear cataract formation (Truscott & Augusteyn, 1977a). Because the levels of HAL, LAN, and LAL were reported to
be much higher in cataract lenses than in normal lenses (Bessems et al.,
1987; Linetsky et al., 2004), crosslinked peptides were expected to be
more easily detected in cataract lenses. Five crosslinked peptides
corresponding to four sites of crosslinking were identified in the ureainsoluble fraction of the nuclear region of one human cataract lens as
shown in Table 2, Fig. 5, and Fig. S5 (Supporting information). Assignment of crosslinked peptides was based on both accurate mass
measurement and their tandem mass spectra.
One crosslinked peptide corresponds to a crosslink between two bB2crystallin peptides 69-81 and 198-205. The tandem mass spectrum of
this crosslinked product (Fig. 5A) indicates that residues K76 and S204
are involved in the crosslink. The identification of the peptides involved
was deduced based on a series of b- and y-ions from peptide 69-81 and
several b- and y-ions, as well as a strong y3 ion corresponding to
N-terminal cleavage of the proline residue provided additional support
for the presence of peptide 198-205. The tandem mass spectrum shown
in Fig. 5B supports crosslinking between bA3-crystallin 46-64 and
bA4-crystallin 2-7 peptides through residues Ser59 of bA3 and Cys5 of
bA4 via a thioether linkage to Ser59.
Additional crosslinked peptides were observed as shown in Fig. S5
(Supporting information) where, in one case, a nondisulfide crosslink
was observed between two cysteine residues with the loss of one
molecule of H2S, suggesting DHA formation from one of the cysteine
residues. The identification of this peptide crosslinked by a thioether
bond, rather than a disulfide bond, was deduced based on sequence
analysis of bA4 159-174 linked to bA4 2-7. Because peptide bA4 2-7 is
short and N-acetylated, there were only two fragment ions above the
noise level from this peptide; however, an additional crosslinked peptide
(bA4 4-7 linked to bA4 159-174) was detected involving the same Cys 5
and Cys 166 residues of bA4-crystallin. The bA4 4-7 peptide could be
generated from protein truncation that is widespread in the lens (Lampi
et al., 1998; Grey & Schey, 2009; Su et al., 2012). Fig. S5B (Supporting
information) indicates a crosslink between bB1-crystallin 74-86 and
cS-crystallin 126-131 through residues Ser77 on bB1-crystallin and
Cys130 on cS-crystallin. The strong neutral loss of 64 Da confirmed
Met46 oxidation, and the y12 and y13 ions confirm carbamidomethylation of Cys52.
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(A)

(B)

(C)

(D)

(E)

Fig. 3 Formation of DHA from a phosphoserine (pSer) peptide and the subsequent addition of GSH and PE. HPLC traces showing: (A) the formation of Ac-YAPSW and
Ac-YAP(DHA)W following incubation of Ac-YAP(pSer)W in 100 mM phosphate buffer pH 7.4 for 15 days at 60 °C, (B) Ac-YAP(DHA)W isolated from the above incubation
and characterized by NMR (Fig. S3), (C) Products formed when Ac-YAP(DHA)W was incubated in 100 mM phosphate buffer pH 7.4 for 24 h at 37 °C with a tenfold molar
excess of phenylethylamine (PE), (D) Products formed when Ac-YAP(DHA)W was incubated under the same conditions with GSH. Cys-Gly adducts are indicated by an
asterisk. (E) Time course of GSH adduct formation from Ac-YAP(DHA)W. Ac-YAP(DHA)W was incubated at 37 °C with a tenfold molar excess of GSH in 100 mM
phosphate buffer pH 7.4, and adduct formation was monitored over time by HPLC. Detection was at 280 nm.

Discussion
Beta-elimination of phosphate from phosphoserine and phosphothreonine occurs readily under basic conditions; however, as demonstrated in
the current study, DHA can also arise from phosphoserine in peptides at
physiological pH. DHA has been detected long-lived proteins such as
dentin (Masters, 1985; Cloos & Jensen, 2000) and lens proteins
(Srivastava et al., 2004), providing indirect evidence for serine or
phosphoserine decomposition. Previously, Linetsky et al. reported glutathionylation of lens proteins presumably through nucleophilic addition
to DHA (Linetsky & LeGrand, 2005); however, the ELISA technique used

in that study could not identify the specific protein residues that were
modified and could not confirm the type of bond formed. This current
report confirms the nucleophilic addition of GSH, and its metabolites, to
DHA residues in lens proteins and, for the first time, reports the
identification of the proteins and residues that have been modified.
Although DHA can be formed from either Ser or Cys, correlation of our
data with lens phosphoproteomic data suggests that the majority of
DHA in normal human lenses is produced by beta-elimination of
phosphate from phosphoserine. Evidence for the formation of DHB from
phosphothreonine and DHA from cysteine was also found. Previously,
DHA has been reported to react with the imidazole group of His and the
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Table 1 Modification sites identified in normal human lenses
Sites that are modified by
Proteins

GSH

Gly-Cys

Cys

Beta-crystallin A3
Beta-crystallin B2
Beta-crystallin B1
Alpha-crystallin A
Alpha-crystallin B
Gamma-crystallin D
Gamma-crystallin D
Gamma-crystallin S
Catenin beta-1
Limbic system-associated membrane protein
Junctional adhesion molecule
Beta-crystallin A2
MP20
AQP0
Connexin 50

S51, S59,S200

S59, S200
S148
S97, S189, S190
S59
S59
S40
S607
S90, S172

S59
S148
S81
S20, S59
S59

S91

S91
S110
S146/S147
S170
S229, S235

T47, S97, T248
S13, S20, S59, S62, T148, S162
S53, S59, T170†, S138/S139
S488, S607
S90
T551/S552
S91

S34†
S231, S235, S245
S259

S146/S147
S170
S229, S235

Homo Cys

Lys
S200
S148
S81

S59
S40

S90

†

Sites not previously reported as phosphorylation sites.

Table 2 Crosslinked peptides identified in a cataract lens nucleus

Fig. 4 The level of glutathionylation of aB-crystallin S59 in the combined watersoluble and urea-soluble fractions from different regions of human lenses: The
relative level of glutathionylation of S59 of aB-crystallin 57-69 relative to the level
of unmodified peptide was measured in outer cortex, inner cortex, and nucleus
regions of two human lenses (32 and 56 years old). Note that the ratio of the top
six fragment ion intensities for each peptide are reported and, due to different
fragmentation patterns, the ratios do not reflect the absolute ratio of peptide
abundances. Error bars represent standard deviation calculated from replicate
injections (n = 2) of the same samples.

e-amine group of Lys (Kanayama et al., 1987); however, we did not
detect His modification and only detected a few sites modified by Lys,
which could reflect the relatively low level of free His and Lys in the lens.
In vitro peptide incubations demonstrated that b-elimination of
phosphoserine within a peptide to form a DHA residue, and the
subsequent nucleophilic addition of either GSH or the Lys analogue,
phenylethylamine, could occur spontaneously under physiological conditions (Fig. 3). Thus, proteins modified by thioether formation with GSH
could be expected in long-lived proteins especially because crystallins
present in the ocular lens are bathed in mM concentrations of GSH.
Glutathione plays a major role in the maintenance and regulation of
the thiol redox status of most cells, but is particularly important in the
lens (Lou, 2003) where there is a concentration gradient from almost

Crosslinked peptides

[MH]+ calc.

[MH]+ obs.

Error
(ppm)

bB2: GEQFVFEK†GEYPR
bB2: GAFHPS†N(deamination)
bB1: AEFS†GECSNLADR
cS: EIHSC†K
bA3: M(ox)EFTSSC(alkylated)
PNVSERS†FDNVR
bA4: acetyl-TLQC†TK
bA4: GFQYVLEC†DHHSGDYK
bA4: acetyl-TLQC†TK
bA4: GFQYVLEC†DHHSGDYK
bA4: pQC†TK

2297.0622

2297.0577

1.97

2152.9386

2152.9396

0.47

2994.3390

2994.3235

1.23

2598.1929

2598.1882

1.82

2325.0241

2325.0192

2.11

pQ, pyroglutamic acid.
All masses listed are monoisotopic masses.
†
The residues that are involved in crosslinking.

10 mM in the outer cortical cell layers to approximately 1 mM in the
center of the lens (Harding, 1970). Increasing oxidative stress and
decreased GSH levels are associated with nuclear cataractogenesis
(Harding, 1970; Spector, 1995), and significant oxidation of protein is
the feature that differentiates cataract lenses from aged-matched
normal lenses (Truscott, 2005). It is important to distinguish the novel
glutathionylation described in this report from the addition of GSH to
proteins that occurs via disulfide bonds (Harding, 1970) and is a common
reversible process that takes place when cells are exposed to oxidative
stress. The irreversible glutathionylation process reported here would
consume GSH in fiber cells and further decrease the concentration of
GSH in the nucleus where the GSH synthesis and recycling pathways are
presumed to be negligible (Rathbun, 1984). The functional consequences of the thiol modifications identified in this report are difficult to
predict. Because the thiol modifications reported here occur on known
phosphorylation sites, these age-related modifications could influence
the structure and function of the modified proteins, particularly protein–
protein interactions and perhaps cell signaling events that are regulated
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(A)

(B)
Fig. 5 Tandem mass spectra of crosslinked
peptides identified in a cataract lens
nucleus: Tandem mass spectra of two
crosslinked peptides are shown and
observed fragments annotated for each
peptide chain as a- or b-chains. (A):
Crosslinked peptide between bB2 69-81:
GEQFVFEKGEYPR (a) and bB2 198-205:
GAFHPSN (b) through K76 and S204. (B):
Crosslinked peptide between bA3 46-64:
MEFTSSCPNVSERSFDNVR (a) and bA4 2-7:
acetyl-TLQCTK (b) through S59 and C5.

by phosphorylation. However, thioether modification by GSH also
prevents DHA and DHB residues from further reaction to form
protein–protein crosslinks that are likely to have more deleterious
functional consequences. Thus, the irreversible thioether modifications
may be protective against age-related protein aggregation.
The aggregation, crosslinking, and insolubilization of crystallins in the
lens with age have been widely studied but remain poorly understood. A
variety of post-translational modifications such as disulfide bonding
(Truscott & Augusteyn, 1977b), glycation (Nagaraj et al., 1991), and
transglutaminase-mediated crosslinking (Lorand et al., 1981) to crystallins could contribute to the protein aggregation, crosslinking and
eventually lead to insolubilization. Crystallin aggregation and crosslinking are believed to form light-scattering centers and contribute to the
development of cataract (Kanayama et al., 1987). A previous study
characterized covalent multimers of crystallins from aging human lens by
2D-gel electrophoresis and mass spectrometry and reported two types of
multimers including those containing eight different crystallins and
others containing crystallins and beaded filaments (Srivastava et al.,
2004); however, because as many as eight proteins were identified from
a single gel spot, a question remains as to whether they all belong to a
single covalently linked complex. In addition, detailed information on
how and where these proteins are linked together remains unknown. In
this report, we identified five crosslinked peptides in a 68-year-old
cataractous lens nucleus that are presumably formed through DHA
intermediates (ii).
For crosslinking to occur, the DHA (or DHB) intermediates (ii) and
nucleophilic groups must be in close proximity to each other in the cell.
Therefore, identification of crosslinked residues (iv) can provide important information on protein–protein interactions within the lens and
potentially about the initiation and progression of protein aggregation
(v). Amino- and carboxy-terminal regions in many proteins are commonly
involved in the contacts between domains and subunits and stabilize the
tertiary and quaternary structures by effectively tying the domains or
subunits together (Thornton & Sibanda, 1983). The proximity of the
crosslinked regions identified in this study could not be confirmed using
currently available crystal structures because they do not provide distal

N-terminal or C-terminal information. Four of the five protein–protein
crosslinks identified in this study involve terminal regions. Moreover, all
crosslinked peptides identified involve b-crystallins, a family of crystallins
that are known to form dimers or oligomers. b-Crystallins contain an
N-terminal extension and a C-terminal extension that are involved in the
self-association to dimers and possibly higher oligomers (Mayr et al.,
1994).
Using our current data, we could not distinguish whether crosslinks
between identical protein subunits occur intermolecularly or intramolecularly. X-ray crystallography of bB2-crystallin has revealed a
two-domain structure where the N- and C-terminal domains of one
bB2-polypeptide are not in close contact, but are separated by an
extended connecting peptide (Bax et al., 1990). Intriguingly the crystal
structure showed a homodimer where the C-terminal domain of one
bB2-crystallin subunit aligned next to the N-terminal domain of the other
bB2-crystallin subunit (Bax et al., 1990). It seems very unlikely therefore
that the crosslinked bB2-peptides involving residues 68-81 and residues
198-205 could come from a single bB2-subunit. This finding strongly
suggests that bB2-crystallin exists as a homodimer in the intact lens. In a
similar manner, bA4-crystallin is also reported to associate as a
homodimer (Slingsby & Bateman, 1990), which may bring residues
Cys5 and C166 in close proximity, intermolecularly, and, again, the
crosslinking data provide evidence that this may be the form of the
protein in vivo. The discovery of bB1-crystallin crosslinked to cS-crystallin
(Fig. S4) confirms that these two proteins are packed closely together in
the lens.
In summary, in normal lenses where GSH is abundant, the spontaneous generation of DHA and DHB residues (ii) in the long-lived
structural proteins is most likely to result in irreversible GSH addition (iii)
to the crystallins. Once GSH levels fall substantially, as they do in the
earliest stage of nuclear cataract (Truscott & Augusteyn, 1977a), protein
crosslinking (iv) is the inevitable result. Therefore, the thiol metabolite
adducts (iii) may play a protective role in preventing protein–protein
crosslinking (iv) and aggregation (v). This scenario is supported by results
that show much higher levels of nondisulfide crosslinking of proteins
from cataract than from normal lenses (Truscott & Augusteyn, 1977b;
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Linetsky et al., 2004). The fact that the extent of this novel covalent
crosslinking increases significantly as the cataract worsens (Truscott &
Augusteyn, 1977a) implies that this process and the mechanisms
described in this paper could well play a key role in the formation of
protein aggregates (v) leading to lens opacities.
In conclusion, this study, for the first time, identifies the sites in
proteins that have been irreversibly modified by GSH and its metabolite
as well as crosslinked through DHA- and DHB-mediated nucleophilic
addition reactions. Moreover, we demonstrate that both DHA formation
and nucleophilic addition can occur spontaneously under physiological
conditions. Phosphoserine and phosphothreonine residues therefore are
susceptible sites for spontaneous breakdown in long-lived proteins.
Thus, the results presented here provide an important contribution to
our understanding of protein aging, protein–protein aggregation, and
potential mechanisms of cataract development. Furthermore, it is likely
that similar modifications and protein–protein crosslinking reactions also
take place in other long-lived cells, for example those in brain, cardiac
muscle, and skin. The strategy and methods reported in this paper can
be applied to search for similar modifications and crosslinking in other
tissues.

Experimental procedures

(pH 8.0), and incubated with 1 lg of trypsin for another 18 h at 37 °C
to reduce the number of missed cleavages. Tryptic peptides were
reduced a second time in 10 mM TCEP at room temperature for 30 min
followed by alkylation with 50 mM iodoacetamide at room temperature
for 45 min. to insure complete reduction/alkylation. The peptides were
cleaned up using a Sep-Pak C18 cartridge as described above. The
sample was dried in a SpeedVac and tryptic peptides were offlinefractionated by strong cation exchange as described previously (Wang &
Schey, 2011). Briefly, bound peptides were step-eluted sequentially from
SCX resins by 40%, 60%, and 100% buffer B (5 mM potassium
phosphate buffer containing 30% ACN, 350 mM KCl, pH 2.5) balanced
with buffer A (5 mM potassium phosphate buffer containing 30% ACN,
pH 2.5). The 60% buffer B eluate was dried in a Speedvac and
reconstituted in 0.1% formic acid. The peptides were desalted using a
C18 Ziptip (Millipore, Billerica, MA, USA) and eluted in 70% ACN (0.1%
formic acid). The eluate was dried in a Speedvac and reconstituted in
0.1% formic acid and loaded onto a custom-packed SCX trap column
(6 cm 9 150 lm, Jupiter C18, 5 lm, 300 
A). Twenty microliters of
750 mM ammonium acetate was flowed through the column, and the
remaining bound peptides were eluted by 30 lL of 3 M ammonium
acetate, and the 3 M ammonium acetate eluate was used for crosslinked
peptide identification by LC-MS/MS.

Lens protein fractionation and trypsin digestion

In vitro formation of DHA and glutathionylated peptides:

Frozen human lenses (aged 32, 56, 58, 68 cataract, and 94 years) were
obtained from NDRI (Philadelphia, PA, USA). A half human lens was
decapsulated and homogenized in homogenizing buffer containing
25 mM Tris (pH 8), 5 mM EDTA, 1 mM DTT, 150 mM NaCl, 1% (v/v)
phosphatase inhibitor (Sigma P5726, St. Louis, MO, USA), and 1%
protease inhibitor (Sigma P8340). Lens proteins were then fractionated
into WSF, USF, and urea-insoluble fraction (UIF) as previously described
(Wang, et al., 2010) except that centrifugation at 100 000 g was used.
Reduction using DTT and alkylation using iodoacetamide were accomplished as previously described (Wang et al., 2010). The UIF was
centrifuged at 100 000 g for 20 min to remove excess iodoacetamide
followed by a water wash. WIF and USF were filtered using a 10-kDa
MWCO (Millipore, Billerica, MA, USA) filter to remove the protease
inhibitor and urea. All samples were resuspended in 100 lL of 10% ACN
in 50 mM ammonium bicarbonate buffer (pH 8.0). Sequencing-grade
modified trypsin (enzyme/substrate = 1/500, Promega, Madison, WI,
USA) was added and samples were incubated at 37 °C for 18 h. After
digestion, samples were centrifuged at 20 000 g for 10 min, and the
supernatant was collected and the remaining pellets were extracted by
ACN (0.1% formic acid). The ACN extract was dried by SpeedVac and
reconstituted in 5% ACN in 0.1% formic acid. The ACN extracts were
pooled together with the supernatant and diluted fivefold by 0.1%
formic acid and loaded onto a Sep-Pak C18 cartridge (Waters Corporation, Milford, MA, USA). The cartridge was washed with 0.1% formic
acid and the bound peptides were eluted by 75% ACN (0.1% formic
acid). Samples were then dried in a SpeedVac and stored at 20 °C until
further analysis.

To confirm that irreversible glutathionylation can occur spontaneously
under physiological conditions, in vitro reactions were performed using
lens protein-related peptides. A human AQP0 phosphopeptide 224-241
(phosphorylation on S235) was synthesized (MUSC Biotechnology Core
Facility). A solution containing a final concentration of 0.5 mg mL 1
AQP0 peptide, 3 mM glutathione, and 5 mM TCEP in 100 mM phosphate
buffer (pH 7.4) was prepared. The mixture was bubbled with nitrogen
and incubated at 37 °C for 3 days. After 3 days, 10 lL of the sample
was mixed with 1 lL of 0.5 mg mL 1 of endoproteinase LysC and the
sample was incubated at 37 °C for 6 h and diluted tenfold by 0.1%
formic acid. Lys C digestion was used to generate the same peptide
detected in human lens digests and analyzed by 1D-LC-MS/MS.
In addition, an N-terminal acetylated peptide containing a phosphorylated Ser derived from the sequence of alpha B-crystallin [Ac-YAP(pSer)
W] was synthesized (GLS Biochem, Shanghai, China). The peptide was
incubated in 100 mM phosphate buffer pH 7.4 at 60 °C to promote the
formation of DHA. Ac-YAP(DHA)W was purified using HPLC, and the
formation of DHA was confirmed by mass spectrometry and NMR
spectroscopy. Ac-YAP(DHA)W was incubated with GSH or phenylethylamine in 100 mM phosphate buffer pH 7.4 at 37 °C. The glutathionylated peptide product was again purified by HPLC and its structure
confirmed by mass spectrometry. The time course of glutathionylation of
the peptide was studied by incubating the purified Ac-YAP (DHA)W with
GSH at 37 °C.

Crosslinked peptide enrichment and identification
To identify crosslinked peptides formed in vivo, the lens nucleus was
isolated from a quarter of a cataract lens (68 years old). The lens
membrane fraction was prepared according to the methods described
above. Tryptic peptides were extracted from the membrane pellets as
described above, resuspended in 50 mM ammonium bicarbonate buffer

The level of glutathionylation on S59 of aB-crystallin in
different regions of the lens
To study the level of glutathionylation in the different regions of the lens,
two human lenses (32 and 56 years) were dissected into outer cortex
(about 0.5-mm-thick layer from the surface), inner cortex (about 1-mmthick layer), and nucleus regions. The water-soluble and urea-soluble
fractions were mixed together. The total protein per sample (500 lg)
was reduced, alkylated, and digested as described above. Aliquots
(0.25 lg) of each sample were analyzed by targeted LC-MS/MS (pseudo
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MRM) on LTQ Velos Pro. Both unmodified and GSH-modified aB 57-69
peptides were targeted by selecting their respective precursor ions and
monitoring their fragment ion intensities in the MS/MS experiment. The
integrated peak areas of top six transitions were calculated using Skyline
software (MacLean et al., 2010). The total peak area of glutathionylated
peptide was normalized by that of the unmodified peptide. Two
injections were made per lens section.
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LC-MS/MS
Tryptic peptides were either separated on a one-dimensional fused silica
capillary column (150 mm 9 75 lm) packed with Phenomenex Jupiter
resin (3 lm mean particle size, 300 
A pore size) or analyzed by
multidimensional LC-MS/MS. One-dimensional liquid chromatography
was employed using the following gradient at a flow rate of
0.4 lL min 1: 0–10 min: 2% ACN (0.1% formic acid), 10–50 min:
2–35% ACN (0.1% formic acid), 50–60 min: 35–90% ACN (0.1%
formic acid) balanced with 0.1% formic acid. The eluate was directly
infused into an LTQ Velos mass spectrometer (ThermoFisher, San Jose,
CA, USA) equipped with a nanoelectrospray source. To identify the sites
of DHA- and DHB-mediated modification, trypsin digests of lens fiber cell
membrane fraction prepared from a 37-year-old and 58-year-old lens
were analyzed by an 11-step multidimensional LC-MS/MS method as
described previously (Wang et al., 2012). For crosslinked peptide
identification, the sample was analyzed using 3-step salt pulse gradient
(1 M, 1.5 M, and 2 M ammonium acetate) over a biphasic (SCX, C18)
column. All LC-MS/MS analyses were run on a Velos Orbitrap mass
spectrometer (ThermoFisher, San Jose, CA, USA). Dynamic exclusion
(repeat count 2, exclusion list size 300, and exclusion duration 60 s) was
enabled to allow the detection of less-abundant ions for all LC-MS/MS
analyses.

Data analysis
Tandem mass spectra were analyzed using a suite of custom-developed
bioinformatics tools. All MS/MS spectra were converted to mzML files by
Scansifter and searched on a 2500 node Linux cluster supercomputer
using a custom version of the TagRecon algorithm (Dasari et al., 2010).
Trypsin specificity was used with a maximum two missed cleavage sites.
To identify unknown post-translational modifications, the data were
searched against a custom human lens protein database using the
TagRecon Blind searching algorithm. Once the mass shifts were
identified, the data were then re-searched with differential modifications
as well as a static modification of carbamidomethylation of cysteine and
variable modification of oxidation of methionine and deamination of
asparagine and glutamine. The identification of each modification
reported required < 5 ppm mass accuracy and manual verification of the
tandem mass spectra. In addition, a neutral loss of 129 due to facile loss
of pyroglutamic acid was required to identify glutathionylated peptides.
For identifying crosslinked peptides, raw data were converted to MGF
files by Scansifter, and crosslinked peptides were identified based on the
combination of manual interpretation, analysis by Proteome Discoverer
1.1.0 (ThermoScientific, San Jose, CA, USA), a TagRecon blind search,
and the MassMatrix algorithm (Xu et al., 2008). MS data were searched
with mass tolerance of 5 ppm and a maximum mass error of 0.5 l for
MS/MS data. Crosslinks between Ser/Thr and Lys/His/Cys were searched
using a mass shift of 18.01051 Da due to the elimination of H2O
during crosslink formation. The possibility of formation of DHA from
cysteine residues via the loss of H2S was also considered.
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